1. Home
  2. MAIN vs GH Comparison

MAIN vs GH Comparison

Compare MAIN & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIN
  • GH
  • Stock Information
  • Founded
  • MAIN 2007
  • GH 2011
  • Country
  • MAIN United States
  • GH United States
  • Employees
  • MAIN N/A
  • GH N/A
  • Industry
  • MAIN Finance/Investors Services
  • GH Medical Specialities
  • Sector
  • MAIN Finance
  • GH Health Care
  • Exchange
  • MAIN Nasdaq
  • GH Nasdaq
  • Market Cap
  • MAIN 5.2B
  • GH 6.1B
  • IPO Year
  • MAIN 2007
  • GH 2018
  • Fundamental
  • Price
  • MAIN $62.26
  • GH $42.87
  • Analyst Decision
  • MAIN Hold
  • GH Strong Buy
  • Analyst Count
  • MAIN 5
  • GH 18
  • Target Price
  • MAIN $48.80
  • GH $44.88
  • AVG Volume (30 Days)
  • MAIN 479.2K
  • GH 2.3M
  • Earning Date
  • MAIN 02-27-2025
  • GH 02-20-2025
  • Dividend Yield
  • MAIN 6.17%
  • GH N/A
  • EPS Growth
  • MAIN 11.78
  • GH N/A
  • EPS
  • MAIN 5.51
  • GH N/A
  • Revenue
  • MAIN $529,897,000.00
  • GH $739,016,000.00
  • Revenue This Year
  • MAIN $10.58
  • GH $33.18
  • Revenue Next Year
  • MAIN $5.22
  • GH $16.41
  • P/E Ratio
  • MAIN $11.30
  • GH N/A
  • Revenue Growth
  • MAIN 9.27
  • GH 31.04
  • 52 Week Low
  • MAIN $44.92
  • GH $15.81
  • 52 Week High
  • MAIN $63.32
  • GH $50.89
  • Technical
  • Relative Strength Index (RSI)
  • MAIN 62.39
  • GH 45.70
  • Support Level
  • MAIN $59.34
  • GH $47.03
  • Resistance Level
  • MAIN $63.25
  • GH $49.90
  • Average True Range (ATR)
  • MAIN 0.91
  • GH 2.62
  • MACD
  • MAIN 0.01
  • GH -0.60
  • Stochastic Oscillator
  • MAIN 73.46
  • GH 13.32

About MAIN Main Street Capital Corporation

Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing's, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.

About GH Guardant Health Inc.

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: